Useful Biomarkers of Metabolic Syndrome
1. Introduction
2. Useful Biomarkers of Metabolic Syndrome
2.1. Adipokines
2.2. Inflammatory and Oxidative Stress Biomarkers
Author Contributions
Funding
Conflicts of Interest
References
- Saklayen, M.G. The global epidemic of the metabolic syndrome. Curr. Hypertens. Rep. 2018, 20, 1–8. [Google Scholar]
- Zafar, U.; Khaliq, S.; Ahmad, H.U.; Manzoor, S.; Lone, K.P. Metabolic syndrome: An update on diagnostic criteria, pathogenesis, and genetic links. Hormones 2018, 17, 299–313. [Google Scholar] [CrossRef] [PubMed]
- Oda, E. Historical perspectives of the metabolic syndrome. Clin. Dermatol. 2018, 36, 3–8. [Google Scholar] [CrossRef]
- Alberti, K.G.M.M.; Zimmet, P.Z. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet. Med. 1998, 15, 539–553. [Google Scholar] [CrossRef]
- Zimmet, P.; Alberti, K.; Shaw, J. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Diabetes Voice 2005, 50, 31–33. [Google Scholar]
- Grundy, S.M.; Cleeman, J.I.; Daniels, S.R.; Donato, K.A.; Eckel, R.H.; Franklin, B.A.; Gordon, D.J.; Krauss, R.M.; Savage, P.J.; Smith, S.C., Jr.; et al. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation 2005, 112, 2735–2752. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Alberti, K.G.; Eckel, R.H.; Grundy, S.M.; Zimmet, P.Z.; Cleeman, J.I.; Donato, K.A.; Fruchart, J.C.; James, W.P.; Loria, C.M.; Smith, S.C., Jr. Harmonizing the metabolic syndrome: A joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American heart association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation 2009, 120, 1640–1645. [Google Scholar]
- Friedman, J. Leptin at 20: An overview. J. Endocrinol. 2014, 223, T1–T8. [Google Scholar] [CrossRef] [Green Version]
- Esteghamati, A.; Noshad, S.; Khalilzadeh, O.; Morteza, A.; Nazeri, A.; Meysamie, A.; Nakhjavani, M. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects. Arch. Med. Res. 2011, 42, 244–251. [Google Scholar]
- Yun, J.E.; Kimm, H.; Jo, J.; Jee, S.H. Serum leptin is associated with metabolic syndrome in obese and nonobese Korean populations. Metabolism 2010, 59, 424–429. [Google Scholar] [CrossRef]
- Madeira, I.; Bordallo, M.A.; Rodrigues, N.C.; Carvalho, C.; Gazolla, F.; Collett-Solberg, P.; Medeiros, C.; Bordallo, A.P.; Borges, M.; Monteiro, C.; et al. Leptin as a predictor of metabolic syndrome in prepubertal children. Arch. Endocrinol. Metab. 2017, 61, 7–13. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Franks, P.W.; Brage, S.; Luan, J.; Ekelund, U.; Rahman, M.; Farooqi, S.; Halsall, I.; O’Rahilly, S.; Wareham, N.J. Leptin predicts a worsening of the features of the metabolic syndrome independently of obesity. Obes. Res. 2005, 13, 1476–1484. [Google Scholar] [CrossRef] [PubMed]
- Ukkola, O.; Kesäniemi, Y.A. Leptin and high-sensitivity C-reactive protein and their interaction in the metabolic syndrome in middle-aged subjects. Metabolism 2007, 56, 1221–1227. [Google Scholar] [CrossRef]
- Lee, K.W.; Shin, D. Prospective associations of serum adiponectin, leptin, and leptin-adiponectin ratio with incidence of metabolic syndrome: The korean genome and epidemiology study. Int. J. Environ. Res. Public Health 2020, 17, 3287. [Google Scholar] [CrossRef] [PubMed]
- Stofkova, A. Leptin and adiponectin: From energy and metabolic dysbalance to inflammation and autoimmunity. Endocr. Regul. 2009, 43, 157–168. [Google Scholar] [PubMed]
- Saely, C.H.; Risch, L.; Hoefle, G.; Rein, P.; Muendlein, A.; Marte, T.; Aczel, S.; Langer, P.; Drexel, H. Low serum adiponectin is independently associated with both the metabolic syndrome and angiographically determined coronary atherosclerosis. Clin. Chim. Acta 2007, 383, 97–102. [Google Scholar] [CrossRef] [PubMed]
- Ryo, M.; Nakamura, T.; Kihara, S.; Kumada, M.; Shibazaki, S.; Takahashi, M.; Nagai, M.; Matsuzawa, Y.; Funahashi, T. Adiponectin as a biomarker of the metabolic syndrome. Circ. J. 2004, 68, 975–981. [Google Scholar] [CrossRef] [Green Version]
- Ahonen, T.; Saltevo, J.; Kautiainen, H.; Kumpusalo, E.; Vanhala, M. The association of adiponectin and low-grade inflammation with the course of metabolic syndrome, Nutrition. Metab. Cardiovasc. Dis. 2012, 22, 285–291. [Google Scholar] [CrossRef]
- Lindberg, S.; Jensen, J.; Bjerre, M.; Frystyk, J.; Flyvbjerg, A.; Jeppesen, J.; Mogelvang, R. Low adiponectin levels at baseline and decreasing adiponectin levels over 10 years of follow-up predict risk of the metabolic syndrome. Diabetes Metab. 2017, 43, 134–139. [Google Scholar] [CrossRef]
- Seino, Y.; Hirose, H.; Saito, I.; Itoh, H. High-molecular-weight adiponectin is a predictor of progression to metabolic syndrome: A population-based 6-year follow-up study in Japanese men. Metabolism 2009, 58, 355–360. [Google Scholar] [CrossRef]
- Falahi, E.; Rad, A.H.K.; Roosta, S. What is the best biomarker for metabolic syndrome diagnosis? Diabetes Metab. Syndr. Clin. Res. Rev. 2015, 9, 366–372. [Google Scholar] [CrossRef] [PubMed]
- Pepys, M.B.; Hirschfield, G.M. C-reactive protein: A critical update. J. Clin. Investig. 2003, 111, 1805–1812. [Google Scholar] [CrossRef] [PubMed]
- Jeong, H.; Baek, S.-Y.; Kim, S.W.; Park, E.-J.; Lee, J.; Kim, H.; Jeon, C.H. C reactive protein level as a marker for dyslipidaemia, diabetes and metabolic syndrome: Results from the Korea National Health and Nutrition Examination Survey. BMJ Open 2019, 9, e029861. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fröhlich, M.; Imhof, A.; Berg, G.; Hutchinson, W.L.; Pepys, M.B.; Boeing, H.; Muche, R.; Brenner, H.; Koenig, W. Association between C-reactive protein and features of the metabolic syndrome: A population-based study. Diabetes Care 2000, 23, 1835–1839. [Google Scholar] [CrossRef] [PubMed]
- Ridker, P.M.; Buring, J.E.; Cook, N.R.; Rifai, N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14 719 initially healthy American women. Circulation 2003, 107, 391–397. [Google Scholar] [CrossRef]
- Kernan, K.F.; Carcillo, J.A. Hyperferritinemia and inflammation. Int. Immunol. 2017, 29, 401–409. [Google Scholar] [CrossRef] [Green Version]
- Ryoo, J.H.; Kim, M.G.; Lee, D.W.; Shin, J.Y. The relationship between serum ferritin and metabolic syndrome in healthy Korean men. Diabetes Metab. Res. Rev. 2011, 27, 597–603. [Google Scholar] [CrossRef]
- Cho, M.R.; Park, J.K.; Choi, W.J.; Cho, A.R.; Lee, Y.J. Serum ferritin level is positively associated with insulin resistance and metabolic syndrome in postmenopausal women: A nationwide population-based study. Maturitas 2017, 103, 3–7. [Google Scholar] [CrossRef]
- Vari, I.S.; Balkau, B.; Kettaneh, A.; André, P.; Tichet, J.; Fumeron, F.; Caces, E.; Marre, M.; Grandchamp, B.; Ducimetière, P.; et al. Ferritin and transferrin are associated with metabolic syndrome abnormalities and their change over time in a general population: Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 2007, 30, 1795–1801. [Google Scholar] [CrossRef] [Green Version]
- Abril-Ulloa, V.; Flores-Mateo, G.; Solà-Alberich, R.; Manuel-y-Keenoy, B.; Arija, V. Ferritin levels and risk of metabolic syndrome: Meta-analysis of observational studies. BMC Public Health 2014, 14, 483. [Google Scholar] [CrossRef] [Green Version]
- Onat, A.; Can, G.; Örnek, E.; Çiçek, G.; Ayhan, E.; Doğan, Y. Serum γ-glutamyltransferase: Independent predictor of risk of diabetes, hypertension, metabolic syndrome, and coronary disease. Obesity 2012, 20, 842–848. [Google Scholar] [CrossRef] [PubMed]
- Yang, W.; Kim, C.K.; Kim, D.Y.; Jeong, H.G.; Lee, S.H. Gamma-glutamyl transferase predicts future stroke: A Korean nationwide study. Ann. Neurol. 2018, 83, 375–386. [Google Scholar] [CrossRef] [PubMed]
- Lee, D.S.; Evans, J.C.; Robins, S.J.; Wilson, P.W.; Albano, I.; Fox, C.S.; Wang, T.J.; Benjamin, E.J.; D’Agostino, R.B.; Vasan, R.S. Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: The Framingham Heart Study. Arter. Thromb. Vasc. Biol. 2007, 27, 127–133. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Jeong, J.; Suh, Y.J. Association between Serum Uric Acid and Metabolic Syndrome in Koreans. J. Korean Med. Sci. 2019, 34, e307. [Google Scholar] [CrossRef] [PubMed]
- Choi, H.K.; Ford, E.S. Prevalence of the metabolic syndrome in individuals with hyperuricemia. Am. J. Med. 2007, 120, 442–447. [Google Scholar] [CrossRef]
- Yadav, D.; Lee, E.S.; Kim, H.M.; Choi, E.; Lim, J.S.; Ahn, S.V.; Koh, S.B.; Chung, C.H. Prospective study of serum uric acid levels and incident metabolic syndrome in a Korean rural cohort. Atherosclerosis 2015, 241, 271–277. [Google Scholar] [CrossRef]
- Yuan, H.; Yu, C.; Li, X.; Sun, L.; Zhu, X.; Zhao, C.; Zhang, Z.; Yang, Z. Serum Uric Acid Levels and Risk of Metabolic Syndrome: A Dose-Response Meta-Analysis of Prospective Studies. J. Clin. Endocrinol. Metab. 2015, 100, 4198–4207. [Google Scholar] [CrossRef]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cho, Y.; Lee, S.Y. Useful Biomarkers of Metabolic Syndrome. Int. J. Environ. Res. Public Health 2022, 19, 15003. https://doi.org/10.3390/ijerph192215003
Cho Y, Lee SY. Useful Biomarkers of Metabolic Syndrome. International Journal of Environmental Research and Public Health. 2022; 19(22):15003. https://doi.org/10.3390/ijerph192215003
Chicago/Turabian StyleCho, Younghye, and Sang Yeoup Lee. 2022. "Useful Biomarkers of Metabolic Syndrome" International Journal of Environmental Research and Public Health 19, no. 22: 15003. https://doi.org/10.3390/ijerph192215003